YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

US allows 1st emergency use of a COVID-19 antibody drug

Posted online

The U.S. Food and Drug Administration on Monday cleared an experimental drug from Eli Lilly for people with mild or moderate COVID-19 symptoms not requiring hospitalization.

The antibody drug, called bamlanivimab, is similar to a treatment President Donald Trump received after contracting the virus last month.  The government previously reached an agreement to buy and supply much of the early production of Lilly’s drug.

Officials say bamlanivimab requires additional testing to establish its safety and effectiveness.

Read more from The Associated Press.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Annual downtown holiday events combine for Nov. 21 celebration

Organizers hope to bolster client traffic to center city businesses.

Most Read
SBJ.net Poll
How often do you use artificial intelligence for your business?

*

View results

Update cookies preferences